Yang, W. (2026). Trilaciclib for myeloprotection in adjuvant and first-line chemotherapy for advanced gastric/gastroesophageal junction adenocarcinoma: A multicohort study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.12152